Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

9.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.7K
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

9.5K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
9.5K
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

778
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
778
mRNA Stability and Gene Expression02:51

mRNA Stability and Gene Expression

6.7K
The structure and stability of mRNA molecules regulates gene expression, as mRNAs are a key step in the pathway from gene to protein. In eukaryotes, the half-life of mRNA varies from a few minutes up to several days. mRNA stability is essential in growth and development. The absence of the proteins regulating its stability, such as tristetraprolin in mice, can cause systemic issues, including bone marrow overgrowth, inflammation, and autoimmunity.
Cis-acting Elements involved in mRNA stability
6.7K
Abnormal Proliferation02:23

Abnormal Proliferation

5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Epigenetic Regulation01:37

Epigenetic Regulation

3.9K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Library Docking for Cannabinoid-2 Receptor Ligands.

Journal of medicinal chemistry·2026
Same author

Identification of novel candidate neural genes for diet-induced obesity in outbred heterogeneous stock rats.

Research square·2026
Same author

Non-Medical Use of Prescription Stimulants in Australia: Prevalence, Sociodemographic and Substance Use Correlates From the 2022-2023 National Drug Strategy Household Survey.

Drug and alcohol review·2026
Same author

Preclinical Comparison of an Injectable In-Situ Scaffold-Forming Oligomeric Collagen for Soft Tissue Volume Augmentation in a Rat Model.

Facial plastic surgery & aesthetic medicine·2026
Same author

Podium Abstracts Presented at the 2025 Annual Meeting of the Arthroscopy Association of North America.

Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association·2026
Same author

Podium Abstracts Presented at the 2025 Annual Meeting of the Arthroscopy Association of North America.

Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association·2026

Related Experiment Video

Updated: Feb 16, 2026

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images
09:42

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images

Published on: September 7, 2017

10.3K

Methylation-regulated decommissioning of multimeric PP2A complexes.

Cheng-Guo Wu1,2, Aiping Zheng1,3, Li Jiang1,4

  • 1McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin at Madison, School of Medicine and Public Health, Madison, WI, 53705, USA.

Nature Communications
|December 24, 2017
PubMed
Summary
This summary is machine-generated.

The butterfly-shaped TIPRL protein inactivates protein phosphatase 2A (PP2A) by binding its catalytic subunit. TIPRL and chaperone α4 work together to disassemble active PP2A, a process controlled by methylation.

More Related Videos

Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications
10:12

Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications

Published on: April 21, 2023

3.7K
Assays for the Degradation of Misfolded Proteins in Cells
10:56

Assays for the Degradation of Misfolded Proteins in Cells

Published on: August 28, 2016

12.6K

Related Experiment Videos

Last Updated: Feb 16, 2026

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images
09:42

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images

Published on: September 7, 2017

10.3K
Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications
10:12

Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications

Published on: April 21, 2023

3.7K
Assays for the Degradation of Misfolded Proteins in Cells
10:56

Assays for the Degradation of Misfolded Proteins in Cells

Published on: August 28, 2016

12.6K

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Dynamic assembly and disassembly of protein complexes are essential for cellular signaling.
  • Protein Phosphatase 2A (PP2A) holoenzymes, composed of scaffold, catalytic, and regulatory subunits, are critical for cellular functions.
  • Specialized chaperones regulate the biogenesis of PP2A holoenzymes.

Purpose of the Study:

  • To elucidate the mechanism by which TIPRL (TOR signaling pathway regulator) interacts with and regulates PP2A holoenzymes.
  • To investigate the role of TIPRL in PP2A holoenzyme assembly, inactivation, and disassembly.
  • To understand how TIPRL and other chaperones, like α4, coordinate PP2A regulation in a methylation-dependent manner.

Main Methods:

  • Structural analysis of TIPRL-PP2A interactions.
  • Biochemical assays to assess PP2A activity and holoenzyme assembly.
  • Investigation of the effects of disease-associated PP2A mutations on TIPRL binding and PP2A function.
  • Studies on the interplay between TIPRL, α4, and PP2A methylation status.

Main Results:

  • TIPRL binds the PP2A catalytic subunit, targeting unmethylated forms and inhibiting phosphatase activity.
  • TIPRL interacts with the PP2A scaffold subunit, accommodating disease mutations that disrupt assembly and enhance inactivation.
  • TIPRL and the latency chaperone α4 cooperate to disassemble active PP2A holoenzymes into latent forms, regulated by methylation.
  • TIPRL's unique binding allows it to tolerate PP2A mutations that impede other regulatory subunits.

Conclusions:

  • TIPRL acts as a key regulator of PP2A, mediating methylation-responsive inactivation and holoenzyme disassembly.
  • The study reveals a novel mechanism for controlling PP2A activity through TIPRL and α4, highlighting the importance of methylation.
  • Understanding TIPRL-PP2A interactions provides insights into cellular signaling complexity and the pathogenesis of diseases linked to PP2A dysfunction, including cancer and intellectual disability.